2022
DOI: 10.1016/j.ijpharm.2022.122333
|View full text |Cite
|
Sign up to set email alerts
|

A comparative study on in vitro and in vivo characteristics of enzalutamide nanocrystals versus amorphous solid dispersions and a better prediction for bioavailability based on “spring-parachute” model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…This supersaturation is explained by temporary prevention of crystallization by the polymer matrix [ 53 , 54 , 55 ]. Thus, the possibly enhanced bioavailability can be assumed [ 24 , 56 , 57 ].…”
Section: Discussionmentioning
confidence: 99%
“…This supersaturation is explained by temporary prevention of crystallization by the polymer matrix [ 53 , 54 , 55 ]. Thus, the possibly enhanced bioavailability can be assumed [ 24 , 56 , 57 ].…”
Section: Discussionmentioning
confidence: 99%
“…The learning has greatly benefited the formulation development. While many industrial precedents focused on the use of polymer (especially for formulations involving amorphous solid dispersions) 46 as a crystallization inhibitor to prevent the neutral form precipitation, we used a cocrystal former (fumaric acid) that serves dual purposes: (1) microenvironmental pH-modulation (pH M ) and (2) formation of a favorable cocrystal that eliminates the freebase produced by disproportionation. The resulting formulation allowed us to achieve target bioavailability by using compendial ingredients in a synergistic way.…”
Section: Introductionmentioning
confidence: 99%